These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8545342)

  • 21. Prostate cancer: enthusiasm for screening.
    Kaye KW
    Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers].
    Villers A; Soulié M; Haillot O; Boccon-Gibod L
    Prog Urol; 1997 Sep; 7(4):655-61. PubMed ID: 9410329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prostate cancer screening].
    Villers A; Rébillard X; Soulié M; Davin JL; Coloby P; Moreau JL; Mejean A; Irani J; Coulange C; Mangin P;
    Prog Urol; 2003 Apr; 13(2):209-14. PubMed ID: 12765053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
    D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
    J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rising prostate specific antigen after radical prostatectomy: a case based review.
    Nasr R; Goldenberg SL
    Can J Urol; 2001 Aug; 8(4):1306-13. PubMed ID: 11564273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostate cancer: view of the horizon].
    Dauriac P
    Rev Infirm; 2004 Mar; (99):18-9. PubMed ID: 15124488
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate cancer: to screen or not to screen?
    Neal DE; Donovan JL
    Lancet Oncol; 2000 Sep; 1(1):17-24. PubMed ID: 11905682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 34. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
    Carlucci JR; Nabizada-Pace F; Samadi DB
    Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiology of prostate cancer in the Limousin area].
    Druet-Cabanac M; Colombeau P; Preux PM; Paulhac P; Vergnenegre A; Dumas JP
    Prog Urol; 2002 Apr; 12(2):226-31. PubMed ID: 12108336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary view of prostate cancer diagnosis and treatment.
    Costello AJ
    Aust Fam Physician; 2003 Jun; 32(6):396-8. PubMed ID: 12833761
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostate cancer: who to screen, and what the results mean.
    Small EJ
    Geriatrics; 1993 Dec; 48(12):28-30, 35-8. PubMed ID: 7504646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.